Abstract Background Metabolic syndrome (MetS) is composed of cardiovascular risk factors
including insulin resistance, obesity, dyslipidemia, and hypertension. Most of the …

AIM: To evaluate the association of metabolic syndrome (MS) and colorectal cancer and
adenomas in a Western country, where the incidence of MS is over 27%. METHODS: This …

Purpose Recently, some studies have shown that diabetes mellitus and metabolic syndrome
increase the risk of colorectal neoplasms. Although the mechanism is not known, those have …

Metabolic syndrome (MetS) and its components has been thought to be involved in the
development of colorectal cancer (CRC). However, the results is often inconsistent …

Background & Aims: Metabolic syndrome and its associated morbidities have become a
major public health problem in both developed and developing countries. Insulin resistance …

Background: Metabolic syndrome (MetS) has been associated with colorectal adenomas
and cancer. However, MetS definitions have changed over time, leading to a heterogeneity …

Background Metabolic syndrome (MetS) has been identified as a contributor to cancer
development. However, reports concerning the association between MetS and colorectal …

BACKGROUND/PURPOSE: Metabolic syndrome (MS) is a cluster of diseases related to
insulin resistance and is an important cardiovascular risk factor. In addition, MS has been …

Abstract Background and Aims: Epidemiologic studies provide evidence for a link between
obesity or diabetes and the risk for colorectal cancer. However, there is a lack of information …

Background: To investigate the association between metabolic syndrome (MetS) and the
risk of colorectal cancer (CRC) in Chinese men, this study was performed based on data …